ICD-10-CM Billable Code

F19.151

Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder with hallucinations

Clinical Classification Guidelines

Medical Intelligence & Overview

ICD-10 Code F19.151 refers to a mental health condition characterized by the misuse of various psychoactive substances that lead to psychotic episodes featuring hallucinations. Such conditions can significantly affect a person’s perception, thinking, and behavior, often requiring comprehensive treatment and support. This guide provides an overview of causes, symptoms, diagnosis, and potential treatment options related to this condition to help improve understanding and awareness.

Causes & Symptoms

Clinical Causes: Prolonged or heavy use of psychoactive substances such as synthetic drugs, hallucinogens, or stimulants. Genetic predisposition or family history of mental health disorders. Pre-existing mental health conditions that may increase vulnerability. Environmental stressors, trauma, or peer influence encouraging substance use. Adolescence or early adulthood, when experimentation with substances is more common.

Key Symptoms: Hallucinations, often auditory or visual, that are vivid and convincing. Disorganized thoughts or speech, making communication difficult. Altered perception of reality, leading to delusional beliefs. Rapid mood swings or agitation. Suspicion or paranoia about others’ intentions. Changes in behavior, such as social withdrawal or risky actions. Physical symptoms like dilated pupils, increased heart rate, sweating, or tremors.

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves a mental health professional conducting a detailed clinical assessment. This includes a comprehensive interview about substance use history, mental health symptoms, and medical history. Doctors may use standardized questionnaires and screening tools to evaluate the severity and impact of symptoms. Psychiatrists also rule out other potential causes of psychosis, such as primary psychiatric disorders or medical conditions. In some cases, laboratory testing or toxicology screens may be performed to confirm recent substance use.

Treatment Protocols: Managing conditions like ICD-10 F19.151 usually involves a multidisciplinary approach. Treatment options include: - **Detoxification:** Supervised medical detox may be necessary to safely manage withdrawal symptoms. - **Medication:** Antipsychotic medications can help control hallucinations and psychosis. Adjunct medications may be used to address symptoms like anxiety or agitation. - **Psychotherapy:** Cognitive-behavioral therapy (CBT) helps patients understand their condition, develop coping strategies, and prevent relapse. - **Substance abuse counseling:** Programs designed to reduce or cease substance use, including support groups and rehabilitation services. - **Supportive care:** Education and support from family, friends, or support groups to aid recovery and social reintegration. Long-term management may involve ongoing therapy and monitoring to address underlying issues related to substance use and mental health.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is F19.151 a billable ICD-10 code?
Yes, F19.151 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report F19.151?
Clinical documentation must specify the nature of Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder with hallucinations and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

substance psychoactive psychotic abuse hallucinations disorder